Systematic review of colchicine neuromyopathy: Risk factors, duration and resolution
- 8 December 2022
- journal article
- research article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 58, 152150
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Update on colchicine, 2017Rheumatology, 2017
- Risk of Colchicine-Associated Myopathy in Gout: Influence of Concomitant Use of StatinThe American Journal of Medicine, 2017
- An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice PopulationThe Journal of Rheumatology, 2015
- Advances in pharmacotherapy for the treatment of goutExpert Opinion on Pharmacotherapy, 2014
- Severe colchicine intoxication after self-administration of colchicine concomitantly with loxoprofenJournal of Anesthesia, 2012
- Colchicine Myotoxicity: Case Reports and Literature ReviewPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2004
- Exocytotic “constipation” is a mechanism of tubulin/lysosomal interaction in colchicine myopathyExperimental Cell Research, 2003
- Fatal colchicine overdose: Report of a case and review of the literatureThe American Journal of Emergency Medicine, 1998
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981
- Massive colchicine overdose: a report on the toxicityThe American Journal of the Medical Sciences, 1976